Advanced Enzyme Technologies Limited — Capital/Financing Update 2025

Jul 25, 2025

July 25, 2025

BSE Limited National Stock Exchange of India Limited P. J. Towers, Exchange Plaza, Plot No. C/1, Dalal Street, G Block, Bandra-Kurla Complex, Mumbai-400 001 Bandra (E) Mumbai-400 051 Scrip Code-540025 Trading Symbol-ADVENZYMES

Dear Sir/Madam,

Subject: Intimation of an Investment proposal approved by the Board of Directors of a subsidiary, JC Biotech Private Limited - Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref: ISIN: INE837H01020

This is to inform that the Board of Directors of JC Biotech Private Limited (“95.72% Subsidiary”) at its

Meeting held on July 25, 2025, has approved a collaboration of the Subsidiary with Raywatt Solar Power Systems Private Limited (“Developer”) engaged in the development of group captive Solar power project, to avail the power / electricity requirement through solar for the said Subsidiary’s Plant located at APIIC Growth centre, Gundlapalli Village, Ongole, Andhra Pradesh.

The Developer would undertake the group captive solar power plant project through a Special Purpose Vehicle company (“SPV”) wherein the buyer of the solar power is required to invest in at least 26% of the said SPV as per the requirement of the applicable laws. In view of this, the said Subsidiary will be required to invest in 26% Equity shares of such SPV.

The relevant details as required under the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024 are enclosed as Annexure - A.

The above information is also made available on the website of the Company at https://www.advancedenzymes.com/investors/stock-exchange-compliance/#other-compliance

This is for your information and for public at large.

Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited

SANJAY PRAKASH Digitally signed by SANJAY PRAKASH BASANTAN BASANTANI Date: 2025.07.25 I 17:12:06 +05'30'

Sanjay Basantani Company Secretary and Head – Legal Encl.: As above

Annexure - A

Annexure - A
Name of the target entity, details in brief such as size, turnover etc	JC Biotech Private Limited (95.72% Subsidiary) in its Board Meeting held today accorded its approval to collaborate with Raywatt Solar Power Systems Private Limited (“Developer”) who is engaged in the development of group captive solar power plant project. In such projects, the Developer undertakes group captive solar power project through a Special Purpose Vehicle company incorporated in India (“SPV”), wherein the buyer of solar power is required to hold atleast 26% equity stake as per the applicable provisions. Hence, the said Subsidiary will be required to invest in 26% Equity Shares of a SPV ("Target Entity") and collaborate with such Developer. The Board of JC Biotech Private Limited, Subsidiary, approved investment in / acquisition of 26% of the Target Entity/SPV to be incorporated in India. Turnover, Profit After Tax: Not Applicable as of now as the Target Entity/SPV is yet to be incorporated/finalized with the developer.
Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length”	Not Applicable
Industry to which the entity being acquired belongs	Special Purpose Vehicle - for generation of Solar Power,GroupCaptive solarpowerplant Project
Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity);	The aforesaid Subsidiary to collaborate with the Developer for setting up a solar power plant through its Special Purpose Vehicle (Target Entity) to meet the power / electricity requirements through solar for the Plant of the Subsidiary located at APIIC Growth centre, Gundlapalli Village, Ongole, Andhra Pradesh, through a sustainable source (solar) and in a cost effective manner from a longtermperspective.
Brief details of any governmental or regulatory approvals required for the acquisition	No such governmental or regulatory approval is required by the Subsidiary for the said amount of investment
Indicative time period for completion of the acquisition	March 31, 2026

	Consideration - whether cash consideration or				Cash Consideration
	share swap or any other	form		and
	details of the same
	Cost of acquisition and/or the price		at	which	Total investment upto₹10 million
	the shares are acquired
	Percentage of shareholding / control		acquired		JC Biotech Private Limited (Subsidiary) to invest
	and/or number of shares				in 26% Equitystake in the Target entity
	Brief background about the entity	acquired in			Brief background: As mentioned above.
	terms of products/line of		business		Target entity presence: India
	acquired, date of incorporation, history			of last	Revenue and Profit After Tax (“PAT”) for		last
	3 years turnover, country	in		which	three Financial Years - Not Applicable as of		now
	the acquired entity has presence and any other				as mentioned above. Post	completion	of
	significant information (in brief)				investment in 26% stake by the	said Subsidiary,
					the said Target Entity will become associate
					companyof the said Subsidiary.